Tom Brady backs a new women’s health milestone as his $2 billion eMed investment pushes forward with GLP-1 research

Tom Brady, the seven time Super Bowl champion, has always remained focused on his health and fitness even as he retired from the league. The NFL icon has been public about working out several times in the day to keep his mind and body refreshed. Amid the new season, tom Brady has marked a new achievement in one of his health tech platforms, eMed.Tom Brady marks an achievement in women’s health as he celebrates his investmentA few hours ago, the New England Patriots’ legend Tom Brady took to his social media to share a post of eMed with a caption that read as, “Love this. GREAT WORK. And so much more to be done.”The post read as, “NEW RESEARCH - 8,127 women. 6 months. One of the largest real-world studies of a structured GLP-1 program ever published.”For the unversed, earlier this year, the seven time Super Bowl champion Tom Brady invested in eMed Population Health, the leading digital health platform for clinically supervised population health management, including GLP-1/GIP therapies.In January 2026, the NFL legend backed a $200 million Series A funding round for the telehealth and digital healthcare startup,which helped push the Miami based company's valuation above $2 billion.The NFL legend officially joined eMed as its founding Chief Wellness Officer in January 2026 and also holds a seat on the company's board of directors.In a press release, the New England Patriots’ icon Tom Brady said, “High-quality medical care should be accessible and delivered responsibly with decisions grounded in medical evidence and individual needs…”Tom Brady added, “At eMed, the focus is improving population health at scale by delivering best-in-class GLP-1 care to workforce populations. These medications can be truly game-changing but only when paired with the right clinical guidance and ongoing support to protect long-term health.”Linda Yaccarino, CEO of eMed, reflected on partnering with Tom Brady as she said, “GLP-1s are triggering a generational shift in healthcare and there’s no turning back…Their adoption is one of the most urgent challenges employers face today, and the need for smarter, more disciplined care around these medications has never been greater.”Linda Yaccarino, CEO of eMed added, “With Tom, we are accelerating our mission to offer a differentiated solution for the future of workplace health.”Tom Brady remains passionate about his investmentsEver since the seven time Super Bowl champion Tom Brady retired from the league, he has turned into a successful entrepreneur and a strategic investor as he has continued to invest in growing and upcoming brands to help them in different industries.Amid all his investments, Tom Brady has continued to work as a sports analyst on FOX Sports even though his reporting has sparked heated debates across the nation.Stay updated with the latest Asian Games 2026 news, check the Asian Games medal tally and complete Asian Games schedule.Get the latest Sports News and Live updates. Download the TOI app.